Order Article Reprints

Boquoi A, Giagounidis A, Goldschmidt H, Heinsch M, Rummel MJ, Kröger N, Mai EK, Strapatsas J, Haas R, Kobbe G. Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation—Results from the LenaMain Trial (NCT00891384). Cancers. 2023; 15(21):5157. https://doi.org/10.3390/cancers15215157

Boquoi, Amelie, Aristoteles Giagounidis, Hartmut Goldschmidt, Michael Heinsch, Mathias J. Rummel, Nicolaus Kröger, Elias K. Mai, Judith Strapatsas, Rainer Haas, and Guido Kobbe. 2023. "Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation—Results from the LenaMain Trial (NCT00891384)" Cancers 15, no. 21: 5157. https://doi.org/10.3390/cancers15215157

Boquoi, A., Giagounidis, A., Goldschmidt, H., Heinsch, M., Rummel, M. J., Kröger, N., Mai, E. K., Strapatsas, J., Haas, R., & Kobbe, G. (2023). Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation—Results from the LenaMain Trial (NCT00891384). Cancers, 15(21), 5157. https://doi.org/10.3390/cancers15215157